Atlas Trials

A Study in Healthy Volunteers of Single Doses of Orally Administered Investigational Product to Investigate Safety, Tolerability, and Pharmacokinecs.

Clinical trial NCT00783549 · COMPLETED

Trial details

NCT number
NCT00783549
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidaemias
Start date
2008-09-04
Primary completion
2009-03-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.